Stay updated on PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial

Sign up to get notified when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The new screenshot shows a redesigned header and page layout; all study details such as eligibility criteria, endpoints, and enrollment appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:15:17.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    6%
    Check dated 2025-10-05T10:24:09.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:21:43.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link has been removed, with no other substantive changes to core content.
    Difference
    0.4%
    Check dated 2025-09-13T17:42:42.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-09-06T15:22:18.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of a new drug, zirconium-89-trastuzumab, while previous location details and drug information have been removed.
    Difference
    2%
    Check dated 2025-08-30T12:01:32.000Z thumbnail image

Stay in the know with updates to PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.